Attovia Therapeutics, Inc. enterprise value

The Enterprise Value as of November 2026 (TTM) for Attovia Therapeutics, Inc. (ATTO) is 664.94M

According to Attovia Therapeutics, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 664.94M. This represents a change of 49.71% compared to the average of 444.14M of the last 4 quarters.

Attovia Therapeutics, Inc. (ATTO) Historical Enterprise Value (quarterly & annually)

How has ATTO Enterprise Value performed in the past?

The mean historical Enterprise Value of Attovia Therapeutics, Inc. over the last ten years is 909.55M. The current 664.94M Enterprise Value has changed -26.89% with respect to the historical average. Over the past ten years (40 quarters), ATTO's Enterprise Value was at its highest in in the June 2026 quarter at 971.26M. The Enterprise Value was at its lowest in in the March 2025 quarter at 0.

Attovia Therapeutics, Inc. (ATTO) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Attovia Therapeutics, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Attovia Therapeutics, Inc. (ATTO) Average Enterprise Value

How has ATTO Enterprise Value performed in the past?

The current Enterprise Value of Attovia Therapeutics, Inc. (ATTO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Attovia Therapeutics, Inc. (ATTO) Enterprise Value vs. Peers

How is ATTO’s Enterprise Value compared to its peers?

Attovia Therapeutics, Inc.’s Enterprise Value is greater than MoonLake Immunotherapeutics (626.18M), less than AnaptysBio, Inc. (1.58B), greater than Connect Biopharma Holdings Limited (24.10M), greater than Aclaris Therapeutics, Inc. (565.21M), greater than Zura Bio Limited (201.50M), greater than Evommune, Inc. (192.32M), greater than Q32 Bio Inc. (164.27M), greater than AgomAb Therapeutics N.V. American Depositary Shares (108.17M), less than Oruka Therapeutics, Inc. (6.15B), less than Alumis Inc. (843.82M),

Build a custom stock screener for Attovia Therapeutics, Inc. (ATTO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Attovia Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Attovia Therapeutics, Inc. (ATTO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Attovia Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.